Welcome to The Pharmacogenomics Journal

The Pharmacogenomics Journal is dedicated to the rapid publication of original research on basic pharmacogenomics research and its clinical applications. Publishing six times a year, the journal aims to provide the highest caliber of coverage concerning the effects of genetic variablity on drug toxicity and efficacy, the characterization of polymorphisms relevant to drug action, and the identification of novel genomic targets for drug development.

Looking for more information on pharmacogenomics? Read about its scope, limitations and applications in this article, featuring The Pharmacogenomics Journal's own Julio Licinio.

*** Announcing The Pharmacogenomics Journal Open ***

The Pharmacogenomics Journal now offers authors the option to publish their articles with immediate open access upon publication. Open access articles will also be deposited on PubMed Central at the time of publication and will be freely available immediately. Find out more from the press release or our FAQs page.

******